Dianthus Therapeutics, Inc. (DNTH)
Healthcare • Biotechnology
StockNasdaqCMUnited StatesUS2528281080
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Dianthus Therapeutics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:41. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 09 Mar 2027 16:00 | -0.99 | — | — | Upcoming |
| 04 Nov 2026 16:00 | -0.95 | -0.81 | +14.6% | Beat |
| 04 Aug 2026 16:00 | -0.91 | -0.90 | +1.0% | In line |
| 05 May 2026 16:00 | -1.10 | -0.85 | +22.9% | Beat |
| 09 Mar 2026 07:00 | -1.03 | -1.43 | -38.6% | Miss |
| 05 Nov 2025 16:00 | -0.90 | -0.97 | -8.0% | Miss |
| 07 Aug 2025 16:00 | -0.87 | -0.88 | -1.5% | Miss |
| 12 May 2025 16:00 | -0.71 | -0.82 | -15.5% | Miss |
| 11 Mar 2025 16:00 | -0.76 | -0.70 | +7.9% | Beat |
| 07 Nov 2024 16:00 | -0.60 | -0.74 | -23.1% | Miss |
| 08 Aug 2024 16:00 | -0.55 | -0.51 | +6.5% | Beat |
| 09 May 2024 16:00 | -0.44 | -0.54 | -23.3% | Miss |
| 21 Mar 2024 16:00 | -1.02 | -0.71 | +30.1% | Beat |
| 09 Nov 2023 16:00 | -0.56 | -3.78 | -575.0% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 2M | -67.3% | -162.3M | -7,973.3% | -4.20 | -64.7% | -129.3M |
| 2024 | 6.2M | +120.6% | -85M | -1,362.8% | -2.55 | +69.8% | -78.3M |
| 2023 | 2.8M | -56.0% | -43.6M | -1,541.2% | -8.45 | -339.7% | -37M |
| 2022 | 6.4M | — | -28.5M | -443.8% | -1.92 | — | -29.2M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 82.46 | 92.79 | 80.34 | 91.46 | +11.03% | 8,739,146 | |
| Oct 2026 | 88.40 | 91.24 | 69.43 | 82.38 | -6.44% | 20,057,400 | |
| Sep 2026 | 105.34 | 111.11 | 84.72 | 88.05 | -16.63% | 18,417,400 | |
| Aug 2026 | 105.64 | 117.88 | 102.38 | 105.61 | -1.23% | 13,578,400 | |
| Jul 2026 | 96.68 | 114.55 | 87.40 | 106.92 | +9.68% | 21,334,700 | |
| Jun 2026 | 91.92 | 98.70 | 68.85 | 97.48 | +4.81% | 31,467,900 | |
| May 2026 | 87.62 | 93.61 | 80.32 | 93.01 | +5.93% | 10,651,300 | |
| Apr 2026 | 85.41 | 96.50 | 81.81 | 87.80 | +4.62% | 13,217,600 | |
| Mar 2026 | 53.84 | 88.02 | 52.07 | 83.92 | +52.06% | 34,831,300 | |
| Feb 2026 | 53.25 | 56.77 | 45.64 | 55.19 | +3.37% | 11,960,600 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Dianthus Therapeutics (DNTH) Stock May Look Stretched As Pipeline Progress Draws Focus (opens in a new tab) Simply Wall St. · 10 Nov 2026 07:09
- Wall Street Analysts See a 61.23% Upside in Dianthus Therapeutics, Inc. (DNTH): Can the Stock Really Move This High? (opens in a new tab) Zacks · 09 Nov 2026 13:55
- Dianthus Therapeutics, Inc. (DNTH) Reports Q3 Loss, Beats Revenue Estimates (opens in a new tab) Zacks · 04 Nov 2026 21:15
- Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 2026 Financial Results (opens in a new tab) 04 Nov 2026 21:01
- Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (opens in a new tab) 02 Nov 2026 22:00
- Dianthus Therapeutics to Participate in Five Investor Conferences During November (opens in a new tab) 02 Nov 2026 21:01
- Dianthus Therapeutics (DNTH) Stock May Be Above Fair Value Following Its 5x Run (opens in a new tab) Simply Wall St. · 20 Oct 2026 10:15
- Dianthus Therapeutics Named to Fortune’s 2026 Best Workplaces in BioPharma List Amid Company Expansion (opens in a new tab) InvestorsHub · 13 Oct 2026 14:52
- Can Dianthus Therapeutics (DNTH) Stay Undervalued Following Its $500 Million Stock Offering? (opens in a new tab) Simply Wall St. · 24 Sep 2026 09:10
- Dianthus Therapeutics (DNTH) Stock Looks Expensive After A 7x Run (opens in a new tab) Simply Wall St. · 24 Sep 2026 03:12
- Dianthus (DNTH) Piles Up Clinical Wins While Its Losses Widen (opens in a new tab) Insider Monkey · 05 Sep 2026 12:30
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 92.48 USD
- Market cap
- 5.2B
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow DNTH and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.